202507.04
30

Application of Section 3(d) on the Intermediate Pharmaceutical compounds

Background In an Appeal from refusal Order of a Patent Application the Delhi High court clarified that even for Intermediate chemical compounds, it is important to show enhanced therapeutic efficacy to overcome objection under section 3(d) and Inventive step of the Intermediate compounds. Intermediate compounds are the compounds which are generated during a chemical reaction….

202507.03
30

Delhi High Court Holds “algorithms” and “computer program” not Patentable

C.A.(COMM.IPD-PAT) 439/2022 The invention claimed in the patent application is a mere sequence of instructions stored in hardware without solving any technical problem or offering any technical advancement to the hardware. The article discusses an appeal filed by Kroll Information Assurance, LLC (Appellant) against the order of Controller General of Patents, Designs and Trademarks (CG)….

202506.30
30

Colour of Confusion: Court Restrains Use of ‘Rainbow’ in Health Sector Feud

Background Rainbow Children’s Medicare Limited (RCML), a well-known hospital chain based in Hyderabad specializing in paediatrics, obstetrics, and gynaecology faced infringement of its rights in the mark/name RAINBOW by a Bengaluru-based firm, Rainbow Healthcare (RH). The case was filed by RCML before Additional City Civil and Sessions Judge, Bengaluru, who eventually dismissed RCML’s application for…

202506.24
3

Egypt Doubles Patent Examination Fees and Revises Payment Deadlines

The Egyptian Intellectual Property Authority (EGIPA) has issued Decree No. 26 of 2025, published in Official Gazette No. 132 on 17 June 2025, introducing key changes to Egypt’s patent system. Effective 18 June 2025, the official patent examination fee has increased from EGP 25,000 to EGP 50,000 (approx. USD 1,060). Additionally, the payment deadline for…

202506.23
30

Delhi High Court Denies AbbVie’s Anti-cMet ADC Patent

C.A.(COMM.IPD-PAT) 44/2023- Delhi High court The article discusses an appeal filed by AbbVie Biotherapeutics Inc. and AbbVie Inc. (Appellants) at the Delhi high Court against the refusal of their Patent application (Application No. 201817047767) for an anti-cMet antibody drug conjugate by Assistant Controller of Patents and Designs. Background of the Case The appellants filed the…

202506.20
30

Bombay High Court denies well-known tag for TikTok in India

TikTok Limited, a technology company operating a social media video application called TikTok, and despite its global outreach and immense popularity worldwide denied coveted well-known status in India. Facts and Background TikTok applied for declaration of its name as a well-known mark in India. The framework for determining whether a trademark is well-know is provided…

202506.16
30

Fair Play questioned: PPL Faces Setback in Licencing Fee Dispute

The Court holds not making copyrighted work available on unreasonable terms could amount to refusal. The court emphasised the balance to be drawn between the interest of the owner of the copyright in protecting their works and the interest of the public to have access to the works This interesting copyright case involves a petition…

202506.10
25

Rankings & Accolades, 2025

RNA is honoured to receive several recognitions and awards this year, which reflects the dedication and passion of our entire team. Each of the individuals and teams listed below have demonstrated exceptional performance and continue to inspire with their leadership. The award motivates us to continue delivering excellence and push boundaries in protecting and enforcing…

202506.09
13

FAQs – Trademark Filing and Prosecution in Nepal

What is the law under which the Trademark Protection is granted in Nepal? Patents, Design and Trade Marks Act, 1965 governs and deals with the mechanism of registration of trademarks in Nepal. Which governmental body is responsible for registration of Intellectual properties in Nepal? The Department of Industry (DOI)is a government body that is responsible…